Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
787.15
-25.7 (-3.16%)
BSENSE

Feb 02

BSE+NSE Vol: 24.52 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
510.19
455.23
406.29
399.87
456.71
436.75
258.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
510.19
455.23
406.29
399.87
456.71
436.75
258.40
Raw Material Cost
271.70
244.55
260.11
244.36
289.21
268.36
141.01
Purchase of Finished goods
6.03
22.91
10.40
3.94
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-10.02
8.09
-35.86
-4.27
1.02
-2.62
-0.97
Employee Cost
64.11
59.33
51.80
46.83
38.48
35.42
32.91
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
94.51
83.50
79.61
73.43
71.42
86.32
52.18
Other Expenses
0.00
0.00
0.00
-0.00
0.02
-0.02
-0.02
Total Expenditure (Excl Depreciation)
426.33
418.38
366.06
364.29
400.15
387.46
225.11
Operating Profit (PBDIT) excl Other Income
83.86
36.85
40.23
35.58
56.56
49.29
33.29
Other Income
7.64
11.89
7.66
7.04
6.06
16.14
3.94
Operating Profit (PBDIT)
91.50
48.74
47.89
42.62
62.62
65.43
37.23
Interest
0.03
0.05
0.19
0.41
0.48
12.06
15.16
Exceptional Items
0.00
9.91
0.00
0.00
0.00
2.88
0.00
Gross Profit (PBDT)
91.47
58.60
47.70
42.21
62.14
56.25
22.07
Depreciation
18.91
17.80
20.53
24.01
25.97
25.90
25.54
Profit Before Tax
72.56
40.80
27.17
18.20
36.18
30.35
-3.47
Tax
17.25
16.46
9.20
2.69
-4.32
3.70
1.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
55.31
24.34
17.97
15.51
40.50
26.66
-4.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
55.31
24.34
17.97
15.51
40.50
26.66
-4.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
55.31
24.34
17.97
15.51
40.50
26.66
-4.62
Equity Capital
13.37
13.37
13.37
13.37
13.37
12.34
12.34
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
19.14
14.66
5.13
2.46
4.22
9.44
-0.78
Operating Profit Margin (Excl OI)
16.44%
8.09%
9.9%
8.9%
12.38%
11.29%
12.88%
Gross Profit Margin
17.93%
12.87%
11.74%
10.56%
13.61%
12.88%
8.54%
PAT Margin
10.84%
5.35%
4.42%
3.88%
8.87%
6.1%
-1.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 12.07% vs 12.05% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 127.24% vs 35.45% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 127.57% vs -8.40% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -40.00% vs -73.68% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Venus Remedies With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
510.19
0
510.19
Other Operating Income
0.00
0.00
0.00
Total Operating income
510.19
0
510.19
Raw Material Cost
271.70
0
271.70
Purchase of Finished goods
6.03
0
6.03
(Increase) / Decrease In Stocks
-10.02
0
-10.02
Employee Cost
64.11
0
64.11
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
94.51
0
94.51
Other Expenses
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
426.33
0
426.33
Operating Profit (PBDIT) excl Other Income
83.86
0.00
83.86
Other Income
7.64
0
7.64
Operating Profit (PBDIT)
91.50
0
91.50
Interest
0.03
0
0.03
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
91.47
0
91.47
Depreciation
18.91
0
18.91
Profit Before Tax
72.56
0
72.56
Tax
17.25
0
17.25
Provisions and contingencies
0.00
0
0.00
Profit After Tax
55.31
0
55.31
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
55.31
0
55.31
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.31
0
55.31
Equity Capital
13.37
0
13.37
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
17.93%
0%
0.00
17.93%
PAT Margin
10.84%
0%
0.00
10.84%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 510.19 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.07% vs 12.05% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 55.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 127.24% vs 35.45% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 83.86 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 127.57% vs -8.40% in Dec 2024

Nine Monthly - Interest
Interest 0.03 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -40.00% vs -73.68% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.44%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024